Avista Corp (AVA)

NYSE

Currency in USD

Disclaimer

37.25

+0.07(+0.19%)

Closed08/10

After Hours

37.53+0.28(+0.75%)

00:35:40

Fair Value

Day's Range

37.17

37.55

52 wk Range

31.10

39.99

Avista (AVA) Income Statement & Profits

Assess the Avista Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

1,345.62

1,321.89

1,438.94

1,710.21

1,751.55

Total Revenues Growth

-3.67%

-1.76%

+8.85%

+18.85%

+2.42%

Total Operating Expenses

1,124.46

1,095.62

1,212.09

1,516.93

1,493.23

	Operating Expenses Growth
	Fuel & Purchased Power
	Operations And Maintenance
	Depreciation & Amortisation, Total
	Other Operating Expenses, Total

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-1.12%	-2.56%	+10.63%	+25.15%	-1.56%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	205.99	224.22	231.92	253.02	265.33
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	918.46	871.4	980.18	1,263.91	1,227.91

Operating Income

221.17

226.27

226.85

193.28

258.32

Operating Income Growth

-14.83%

+2.31%

+0.26%

-14.8%

+33.65%

EBIT Margin %

16.44%

17.12%

15.76%

11.3%

14.75%

Interest Expense, Total

-100.18

-100.98

-102.17

-114.97

-139.67

Other Non Operating Expenses, Total

5.48

7.17

10.13

7.32

7.46

	Income (Loss) on Equity Investment
	Allowance For Equity Funds Used During Construction
	Other Non Operating Income (Expenses)

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6.59	6.97	7	6.7	6.89
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-1.1	0.2	3.13	0.61	0.58

EBT, Excl. Unusual Items

130.51

135.63

137.96

89.49

140.78

Gain (Loss) on Sale of Investments

14.3

0.91

21.4

48.49

-3.23

Gain (Loss) On Sale Of Assets

-

-

-

-

-

EBT, Incl. Unusual Items

228.14

136.54

159.37

137.99

137.55

EBT, Incl. Unusual Items Growth

+40.26%

-40.15%

+16.72%

-13.42%

-0.32%

Income Tax Expense

31.37

7.05

12.03

-17.19

-33.63

Net Income to Company

196.76

129.49

147.33

155.18

171.18

Minority Interest

0.22

-

-

-

-

Net Income

196.98

129.49

147.33

155.18

171.18

Net Income Growth

+44.38%

-34.26%

+13.78%

+5.32%

+10.31%

Net Income Margin %

14.64%

9.8%

10.24%

9.07%

9.77%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

196.98

129.49

147.33

155.18

171.18

Basic EPS - Continuing Operations

2.98

1.91

2.11

2.13

2.24

Basic EPS - Continuing Operations Growth

+43.22%

-35.96%

+10.55%

+0.94%

+5.39%

Diluted EPS - Continuing Operations

2.97

1.9

2.1

2.12

2.24

Diluted EPS - Continuing Operations Growth

+43.48%

-36.03%

+10.53%

+0.95%

+5.66%

Basic Weighted Average Shares Outstanding

66.21

67.96

69.95

72.99

76.4

Diluted Weighted Average Shares Outstanding

66.33

68.1

70.09

73.09

76.5

Dividend Per Share

1.55

1.62

1.69

1.76

1.84

Dividend Per Share Growth

+4.03%

+4.52%

+4.32%

+4.14%

+4.55%

EBITDA

427.16

450.49

459.02

446.42

523.73

EBITDA Growth

-4.44%

+5.46%

+1.89%

-2.75%

+17.32%

EBITDA Margin %

31.74%

34.08%

31.9%

26.1%

29.9%

EBIT

221.17

226.27

226.85

193.28

258.32

* In Millions of USD (except for per share items)

8,190.61

-113.01

-1.36%

19,066.47

-37.63

-0.20%

4,949.65

-20.06

-0.40%

5,751.13

+55.19

+0.97%

39,363.50

+456.00

+1.17%

42,080.37

+126.13

+0.30%

FTSE 100 Futures

8,253.30

+1.1

+0.01%

Name	Last	Chg. %	Vol.
Glencore	417.50	-4.57%	95.89M
BP	406.45	-3.71%	41.01M
Ascential	567.00	0.00%	33.19M
HSBC	666.00	-4.20%	25.90M
Shell	2,576.0	-2.35%	9.99M
Rio Tinto PLC	5,044.0	-4.83%	4.14M
AstraZeneca	11,678.0	-1.12%	2.57M